NCT05641298: Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations |
|
|
| Withdrawn | 2 | 80 | US | Sodium Fusidate, ACG-701, ARV-1801, Placebo | Aceragen | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 09/23 | 09/23 | | |
| Withdrawn | 1 | 30 | US | Dexamethasone Oral | IDeA States Pediatric Clinical Trials Network, National Institutes of Health (NIH), University of Nebraska | Bronchiolitis | 03/25 | 04/25 | | |